NEVADA
|
000-54014
|
20-5093315
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
343 Allerton Ave.
South San Francisco, California 94090
|
(Address of principal executive offices)
|
Title
of each class
|
Trading
Symbol(s)
|
Name of
each exchange on which registered
|
Common
Stock, par value $0.001 per share
|
VTGN
|
Nasdaq
Capital Market
|
|
For
|
Against
|
||
|
Votes
|
%
Voted
|
Votes
|
% Voted
|
Shawn K.
Singh
|
14,657,935
|
91.91%
|
1,290,719
|
8.09%
|
H. Ralph
Snodgrass
|
14,711,550
|
92.24%
|
1,237,104
|
7.76%
|
Jon S.
Saxe
|
13,312,707
|
83.47%
|
2,635,947
|
16.53%
|
Brian J.
Underdown
|
13,306,184
|
83.43%
|
2,642,470
|
16.57%
|
Jerry B.
Gin
|
13,318,049
|
83.51%
|
2,630,605
|
16.49%
|
Ann M.
Cunningham
|
14,727,093
|
92.34%
|
1,221,561
|
7.66%
|
|
For
|
Against
|
Abstained
|
Votes
|
26,509,066
|
4,963,523
|
470,091
|
%
Voted
|
82.99%
|
15.54%
|
1.47%
|
|
For
|
Against
|
Abstained
|
Votes
|
12,884,874
|
2,992,767
|
71,013
|
%
Voted
|
80.79%
|
18.77%
|
0.44%
|
|
For
|
Against
|
Abstained
|
Votes
|
14,572,422
|
1,315,128
|
61,104
|
% Voted
|
91.37%
|
8.25%
|
0.38%
|
|
For
|
Against
|
Abstained
|
Votes
|
13,883,367
|
1,965,028
|
100,259
|
%
Voted
|
87.05%
|
12.32%
|
0.63%
|
|
For
|
Against
|
Abstained
|
Votes
|
30,257,040
|
849,405
|
836,235
|
%
Voted
|
94.72%
|
2.66%
|
2.62%
|
Exhibit No.
|
|
Description
|
|
Certificate
of Amendment to the Restated and Amended Articles of Incorporation,
as amended, of VistaGen Therapeutics, Inc., dated September 6,
2019.
|
|
VISTAGEN THERAPEUTICS,
INC.
|
|
|
|
|
|
|
Date: September 6,
2019
|
By:
|
/s/ Shawn K.
Singh
|
|
|
|
Shawn K.
Singh
|
|
|
|
Chief Executive
Officer
|
|